Izvorni znanstveni članak
https://doi.org/10.24141/1/10/1/2
THE INFLUENCE OF COMORBIDITY ON THE OUTCOME OF THE TREATMENT OF PATIENTS SUFFERING FROM COVID-19
Adis Hrvačić
orcid.org/0000-0001-5961-0389
; Zavod za javno zdravstvo SBK/KSB, Mehmeda Spahe 1, Travnik, Bosna i Hercegovina
*
Velma Rebić
; Medicinski fakultet, Univerzitet u Sarajevu, Čekaluša 90, Sarajevo, Bosna i Hercegovina
Amer Ovčina
orcid.org/0000-0001-9502-4942
; Klinički centar Univerziteta u Sarajevu, Bolnička 25, Sarajevo, Bosna i Hercegovina
* Dopisni autor.
Sažetak
The work aimed to examine the impact of comorbidities on the outcome of treatment of patients with COVID-19 hospitalized in the Travnik Hospital in Travnik. A retrospective analysis of the medical records of patients hospitalized due to COVID-19 in whom infection with the SARS-CoV-2 virus was etiologically confirmed by a positive result of the RT-PCR test was carried out. The study included patients hospitalized between September 16, 2020 and June 15, 2021. During the observed period, a total of 1,874 patients were hospitalized due to COVID-19, of which 1,190 (64%) were men and 684 (36%) were women. Eight patients were younger than 18 years (median 8; range 2-17 years), in other age categories the median was 65 (range 18-95 years). A total of 1179 (62.8%) patients had one or more comorbidities, the most common of which were cardiovascular diseases, including hypertension (49.2%), diabetes (16.6%), and COPD/asthma (3.4%). The most common symptoms of the disease were fever (89.7%), cough (73.7%), dyspnea (45.7%), diarrhea (45.3%) and malaise (33.1%). 313 (16.7%) patients had a mild form of the disease, 692 (36.9%) had a moderate form, 665 (35.5%) had a severe form, and 204 (10.9%) had a critical form. 804 (42.9%) patients needed oxygen treatment, and 365 (19.5%) patients needed treatment in the intensive care unit (ICU). Patients with heart disease and COPD develop significantly more severe symptoms and a relatively higher mortality rate. Infection with the SARS-CoV-2 virus becomes very harmful when it affects a person with comorbidity, therefore, treatment of these patients should be a priority.
Ključne riječi
COVID-19, cardiovascular diseases, COPD; comorbidities, diabetes, SARS-CoV-2
Hrčak ID:
318235
URI
Datum izdavanja:
21.6.2024.
Posjeta: 624 *